SI1225902T1 - Ciclesonide contained pharmaceutical composition for application to mucosa - Google Patents

Ciclesonide contained pharmaceutical composition for application to mucosa

Info

Publication number
SI1225902T1
SI1225902T1 SI200030622T SI200030622T SI1225902T1 SI 1225902 T1 SI1225902 T1 SI 1225902T1 SI 200030622 T SI200030622 T SI 200030622T SI 200030622 T SI200030622 T SI 200030622T SI 1225902 T1 SI1225902 T1 SI 1225902T1
Authority
SI
Slovenia
Prior art keywords
mucosa
application
pharmaceutical composition
contained pharmaceutical
ciclesonide
Prior art date
Application number
SI200030622T
Other languages
English (en)
Slovenian (sl)
Inventor
Atsuhiro Teijin Limited Nagano
Yoshihisa Teijin Limited NISHIBE
Kazuya Teijin Limited Takanashi
Original Assignee
Altana Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=17856327&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI1225902(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Altana Pharma Ag filed Critical Altana Pharma Ag
Publication of SI1225902T1 publication Critical patent/SI1225902T1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0043Nose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/02Nasal agents, e.g. decongestants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SI200030622T 1999-10-20 2000-10-20 Ciclesonide contained pharmaceutical composition for application to mucosa SI1225902T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP29818599 1999-10-20
PCT/JP2000/007350 WO2001028562A1 (en) 1999-10-20 2000-10-20 Ciclesonide contained pharmaceutical composition for application to mucosa

Publications (1)

Publication Number Publication Date
SI1225902T1 true SI1225902T1 (en) 2005-06-30

Family

ID=17856327

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200030622T SI1225902T1 (en) 1999-10-20 2000-10-20 Ciclesonide contained pharmaceutical composition for application to mucosa

Country Status (36)

Country Link
US (1) US6767901B1 (hu)
EP (1) EP1225902B1 (hu)
JP (1) JP4264211B2 (hu)
KR (1) KR100722209B1 (hu)
CN (2) CN101869570B (hu)
AR (1) AR026072A1 (hu)
AT (1) ATE285779T1 (hu)
AU (1) AU781895B2 (hu)
BG (1) BG65818B1 (hu)
BR (1) BRPI0014878B8 (hu)
CA (1) CA2388322C (hu)
CO (1) CO5261494A1 (hu)
CZ (1) CZ297779B6 (hu)
DE (1) DE60017175T2 (hu)
DK (1) DK1225902T3 (hu)
EA (1) EA006015B1 (hu)
ES (1) ES2234681T3 (hu)
HK (2) HK1050858A1 (hu)
HR (1) HRP20020346B1 (hu)
HU (1) HU228893B1 (hu)
IL (2) IL148691A0 (hu)
ME (1) ME00567A (hu)
MX (1) MXPA02003974A (hu)
MY (1) MY136987A (hu)
NO (1) NO327444B1 (hu)
NZ (1) NZ518298A (hu)
PE (1) PE20010712A1 (hu)
PL (1) PL199702B1 (hu)
PT (1) PT1225902E (hu)
RS (1) RS50310B (hu)
SI (1) SI1225902T1 (hu)
SK (1) SK286196B6 (hu)
TR (1) TR200200841T2 (hu)
TW (1) TWI225788B (hu)
WO (1) WO2001028562A1 (hu)
ZA (1) ZA200203077B (hu)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR026073A1 (es) 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica acuosa que contiene ciclesonida
AR026072A1 (es) * 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica que contiene ciclesonida para aplicacion a la mucosa
RS57455B1 (sr) * 2002-07-02 2018-09-28 Astrazeneca Ab Sterilna vodena suspenzija koja sadrži ciklezonid
US7221586B2 (en) 2002-07-08 2007-05-22 Micron Technology, Inc. Memory utilizing oxide nanolaminates
JP2005537347A (ja) * 2002-07-26 2005-12-08 エフ エム シー コーポレーション 微結晶質セルロースの製造
ES2348034T3 (es) * 2002-08-30 2010-11-29 Nycomed Gmbh Uso de la combinacion de ciclesonida y antihistaminas para el tratamiento de la rinitis alergica.
WO2004052374A1 (en) * 2002-12-12 2004-06-24 Altana Pharma Ag Combination medicament
MY143936A (en) 2003-03-27 2011-07-29 Nycomed Gmbh Process for preparing crystalline ciclesonide with defined particle size
DK1670482T4 (da) 2003-09-16 2022-08-22 Covis Pharma B V Anvendelse af ciclesonid til behandlingen af respiratoriske sygdomme
PE20050941A1 (es) * 2003-12-16 2005-11-08 Nycomed Gmbh Suspensiones acuosas de ciclesonida para nebulizacion
CA2563556C (en) * 2004-04-20 2013-01-29 Altana Pharma Ag Use of ciclesonide for the treatment of respiratory diseases in a smoking patient
CA2579007A1 (en) * 2004-09-10 2006-03-16 Altana Pharma Ag Ciclesonide and syk inhibitor combination and methods of use thereof
EP1645266A1 (en) * 2004-10-08 2006-04-12 Hisamitsu Medical Co., Ltd. Aqueous suspension for nasal drops
CA2717984C (en) * 2008-03-14 2013-11-26 Cephalon, Inc. Enhanced transmucosal composition and dosage form
WO2011135585A2 (en) 2010-04-28 2011-11-03 Cadila Healthcare Limited Aqueous pharmaceutical solution of ciclesonide

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63303931A (ja) * 1987-06-05 1988-12-12 Sumitomo Pharmaceut Co Ltd 経鼻投与用成長ホルモン放出活性物質製剤
GB9103824D0 (en) * 1991-02-23 1991-04-10 Fisons Ag Formulation
WO1997001337A1 (en) 1995-06-29 1997-01-16 Mcneil-Ppc, Inc. The combination of topical nasal antihistamines and topical nasal steroids
US6120752A (en) * 1997-05-21 2000-09-19 3M Innovative Properties Company Medicinal aerosol products containing formulations of ciclesonide and related steroids
SE9704186D0 (sv) * 1997-11-14 1997-11-14 Astra Ab New composition of matter
KR100683510B1 (ko) * 1998-01-22 2007-02-16 산텐 세이야꾸 가부시키가이샤 플루오로메톨론 현탁형 점안제
SE514128C2 (sv) 1998-03-17 2001-01-08 Pharmalink Ab Användning av en glukokortikoid för framställning av ett läkemedel för behandling av glomerulonefrit
TWI243687B (en) 1998-04-21 2005-11-21 Teijin Ltd Pharmaceutical composition for application to mucosa
AR026072A1 (es) * 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica que contiene ciclesonida para aplicacion a la mucosa

Also Published As

Publication number Publication date
SK286196B6 (sk) 2008-05-06
CN101869570B (zh) 2012-10-10
CA2388322C (en) 2007-09-18
PT1225902E (pt) 2005-05-31
MXPA02003974A (es) 2003-09-25
HU228893B1 (hu) 2013-06-28
ZA200203077B (en) 2003-02-26
AR026072A1 (es) 2002-12-26
ME00567B (me) 2011-12-20
EP1225902B1 (en) 2004-12-29
NO20021898L (no) 2002-04-22
CA2388322A1 (en) 2001-04-26
TWI225788B (en) 2005-01-01
JP2003512329A (ja) 2003-04-02
AU781895B2 (en) 2005-06-23
HUP0203339A3 (en) 2004-07-28
ES2234681T3 (es) 2005-07-01
CN1379674A (zh) 2002-11-13
KR20020059627A (ko) 2002-07-13
NZ518298A (en) 2003-11-28
DK1225902T3 (da) 2005-05-02
HUP0203339A2 (hu) 2003-02-28
DE60017175D1 (de) 2005-02-03
CN101869570A (zh) 2010-10-27
BR0014878A (pt) 2002-06-11
NO327444B1 (no) 2009-06-29
CO5261494A1 (es) 2003-03-31
EA200200375A1 (ru) 2002-10-31
RS50310B (sr) 2009-09-08
SK6922002A3 (en) 2002-09-10
YU28002A (sh) 2004-11-25
CZ297779B6 (cs) 2007-03-28
IL148691A0 (en) 2002-09-12
EA006015B1 (ru) 2005-08-25
HRP20020346A2 (en) 2004-02-29
CN1379674B (zh) 2014-10-29
TR200200841T2 (tr) 2002-07-22
PL199702B1 (pl) 2008-10-31
CZ20021238A3 (cs) 2002-07-17
DE60017175T2 (de) 2005-12-29
HK1149719A1 (en) 2011-10-14
BG106512A (bg) 2002-12-29
MY136987A (en) 2008-12-31
IL148691A (en) 2006-12-10
EP1225902A1 (en) 2002-07-31
BRPI0014878B8 (pt) 2021-05-25
HRP20020346B1 (en) 2011-06-30
US6767901B1 (en) 2004-07-27
HK1050858A1 (zh) 2003-07-11
ME00567A (en) 2011-12-20
ATE285779T1 (de) 2005-01-15
KR100722209B1 (ko) 2007-05-29
AU7953100A (en) 2001-04-30
PE20010712A1 (es) 2001-07-12
NO20021898D0 (no) 2002-04-22
BRPI0014878B1 (pt) 2015-08-11
BG65818B1 (bg) 2010-01-29
WO2001028562A1 (en) 2001-04-26
PL356191A1 (en) 2004-06-14
JP4264211B2 (ja) 2009-05-13

Similar Documents

Publication Publication Date Title
HK1149719A1 (en) Ciclesonide contained pharmaceutical composition for application to mucosa
HUP0002512A3 (en) Medicinal compositions for application to mucosa
HUP0200879A2 (en) Pharmaceutical composition for dermal use
HUP0204372A3 (en) Pharmaceutical compositions providing enhanced drug concentrations
HUP0202513A3 (en) Betha-carboline pharmaceutical compositions
HUP0201376A2 (en) Thiazoloderivatives and pharmaceutical compositions containing them and process for preparation the compounds
GB0028088D0 (en) Pharmaceutical compositions
HUP0202495A3 (en) Stable medicinal compositions for oral use
GB0001662D0 (en) Pharmaceutical compositions
HUP0203311A3 (en) New pharmaceutical compositions of prolonged effect
HUP0000137A3 (en) Controller-release pharmaceutical composition containing anangetics
GB9904163D0 (en) Pharmaceutical compositions
HUP0200747A2 (en) Pharmaceutical compounds and pharmaceutical compositions containing them
GB9911017D0 (en) Pharmaceutical compositions
IL149422A0 (en) Oral pharmaceutical compositions for liver therapy
GB9904911D0 (en) Pharmaceutical compositions
HUP0200311A3 (en) Use of aroyl- or arylalkanoylpyridazines for preparation of pharmaceutical compositions
GB9902227D0 (en) Pharmaceutical composition for topical administration
EP1210935A4 (en) DRUGS FOR ORAL USE
IL149470A0 (en) Pharmaceutical compositions containing carboxamidoadenosine derivatives
GB9902651D0 (en) Pharmaceutical compositions
EP1188440A4 (en) MEDICINAL COMPOSITION FOR ORAL ADMINISTRATION
GB9916413D0 (en) Pharmaceutical composition
GB9916210D0 (en) Pharmaceutical composition
GB9909073D0 (en) Novel pharmaceutical composition